Preview

Rational Pharmacotherapy in Cardiology

Advanced search

CHANGES IN PREHOSPITAL PHARMACOTHERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME IN 2005-2014 ACCORDING TO THE LIS REGISTER

https://doi.org/10.20996/1819-6446-2014-10-6-631-633

Full Text:

Abstract

Aim. To study changes in prehospital pharmacotherapy with cardiovascular drugs in patients admitted to hospital with acute coronary syndrome (ACS) in 2005-2014.

Material and methods. The data of the LIS register (Lyubertsy study of mortality in patients undergone acute myocardial infarction) were used. Patients that survived 4 days after admission were included in the analysis.

Results. The positive changes in the prescription of antiplatelet agents (13.5% in 2005 and 27.4% in 2014), statins (1.7% and 16.3%, respectively) and angiotensin receptor blockers (0.6% and 8.8%, respectively) were found. The prescription rate of other cardiovascular drug classes did not change significantly.

Conclusion. Registration of treatment prior to ACS can be an important tool for evaluation of quality of ACS and myocardial infarction drug prevention.

About the Authors

S. Y. Martsevich
State Research Centre for Preventive Medicine
Russian Federation
Petroverigsky per. 10, Moscow, 101990 Russia


M. L. Ginzburg
State Research Centre for Preventive Medicine, Lyubertsy Regional Hospital №2
Russian Federation

Petroverigsky per. 10, Moscow, 101990 Russia

Oktyabr’skiy prospect 338, Moscow Region, Lyubertsy, 140006 Russia



N. P. Kutishenko
State Research Centre for Preventive Medicine
Russian Federation
Petroverigsky per. 10, Moscow, 101990 Russia


A. V. Zagrebelnyy
State Research Centre for Preventive Medicine
Russian Federation
Petroverigsky per. 10, Moscow, 101990 Russia


I. S. Balashov
State Research Centre for Preventive Medicine, I.M. Sechenov First Moscow State Medical University
Russian Federation

Petroverigsky per. 10, Moscow, 101990 Russia

Trubetskaya ul. 8-2, Moscow, 119991 Russia



L. G. Garkina
Lyubertsy Regional Hospital №2
Russian Federation
Oktyabr’skiy prospect 338, Moscow Region, Lyubertsy, 140006 Russia


References

1. Martsevich SY, Ginzburg ML, Kutishenko NP, et al. The LIS study (Lubertsy study of mortality in patients with acute myocardial infarction). Evaluation of drug therapy. Part 1. How to treat patients with myocardial infarction before and how it affects the mortality rate in the hospital. Ration Pharmacother Cardiol 2012; 8 (5): 681-4. Russian (Марцевич С.Ю., Гинзбург М.Л., Кутишенко Н.П., и др. Исследование ЛИС (Люберецкое исследование смертности больных, перенесших острый инфаркт миокарда). Оценка лекарственной терапии. Часть 1. Как лечатся больные перед инфарктом миокарда и как это влияет на смертность в стационаре. Рациональная Фармакотерапия в Кардиологии 2012;8(5):681-4).

2. Martsevich SY, Ginzburg ML, Kutishenko NP, et al. The LIS study (Lubertsy study of mortality in patients with acute myocardial infarction) Evaluation of drug therapy Part 2. Effect of prior drug treatment on long-term prognosis of life patients. Ration Pharmacother Cardiol 2012; 8 (6): 738-45. Russian (Марцевич С.Ю., Гинзбург М.Л., Кутишенко Н.П., и др. Исследование ЛИС (Люберецкое исследование смертности больных, перенесших острый инфаркт миокарда) Оценка лекарственной терапии Часть 2. Влияние предшествующей лекарственной терапии на отдаленный прогноз жизни больных. Рациональная Фармакотерапия в Кардиологии 2012;8(6):738-45).

3. McCormick D., Gurwitz J.H., Lessard D., Yarzebski J., Gore J.M., Goldberg R.G. Use of Aspirin, b-Blockers, and Lipid-Lowering Medications Before Recurrent Acute Myocardial Infarction. Missed Opportunities for Prevention? Arch Intern Med 1999;159:561-7.

4. Moscucci M., Share D. Impact of health care initiatives on outcomes of acute coronary syndromes. Heart 2006;92:293-5.

5. Martsevich SY, Ginzburg ML, Kutishenko NP, et al. Lubertsy mortality study (The LIS study): factors affecting the long-term prognosis of life after myocardial infarction. Profilakticheskaya Meditsina 2013; (2): 32-8. Russian (Марцевич С.Ю., Гинзбург М.Л., Кутишенко Н.П., и др. Люберецкое исследование смертности (исследование ЛИС): факторы, влияющие на отдаленный прогноз жизни после перенесенного инфаркта миокарда. Профилактическая Медицина 2013;(2): 32-8).

6. Lukina YV, Ginzburg ML, Smirnov VP, et al. Adherence to treatment, previous hospitalization in patients with acute coronary syndrome. Klinitsist 2012; (2): 41-9. Russian (Лукина Ю.В., Гинзбург М.Л., Смирнов В.П., и др. Приверженность лечению, предшествующему госпитализации, у пациентов с острым коронарным синдромом. Клиницист 2012; (2): 41-9).

7. Ginzburg ML, Martsevich SY, Kutishenko NP, et al. Opportunities register as a quality control tool for outpatient pharmacotherapy in patients at high risk of cardiovascular complications (REGISTER "LIS-1") . Ration Pharmacother Cardiol 2014; 10 (3): 288-92. Russian (Гинзбург М.Л., Марцевич С.Ю., Кутишенко Н.П., и др. Возможности регистра как инструмента контроля качества фармакотерапии на амбулаторном этапе у пациентов с высоким риском сердечно-сосудистых осложнений (РЕГИСТР «ЛИС-1»). Рациональная Фармакотерапия в Кардиологии 2014;10(3):288-92).

8. Yeh R.W., Sidney S., Chandra M., et al. Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction. N Engl J Med 2010;362:2155-65.

9. Ginzburg ML, Martsevich SY, Kutishenko NP, et al. A study of factors affecting the long-term prognosis of patients with myocardial infarction. Russian National Congress of Cardiology - 2011. Kardiovaskulyarnaya Terapiya i Profilaktika 2001; 10 (6) suppl 1: 75. Russian (Гинзбург М.Л., Марцевич С.Ю., Кутишенко Н.П., и др. Изучение факторов, влияющих на отдаленный прогноз пациентов, перенесших инфаркт миокарда. Российский национальный конгресс кардиологов – 2011. Кардиоваскулярная Терапия и Профилактика 2001; 10(6) приложение 1: 75).


Review

For citations:


Martsevich S.Y., Ginzburg M.L., Kutishenko N.P., Zagrebelnyy A.V., Balashov I.S., Garkina L.G. CHANGES IN PREHOSPITAL PHARMACOTHERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME IN 2005-2014 ACCORDING TO THE LIS REGISTER. Rational Pharmacotherapy in Cardiology. 2014;10(6):631-633. (In Russ.) https://doi.org/10.20996/1819-6446-2014-10-6-631-633

Views: 573


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)